| Name | Walgreens #3147 |
|---|---|
| Organization Name | Walgreen Co |
| Location | 918 Riverview Dr, Kalamazoo, Michigan 49048 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (269) 382-8181 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Researchers from the University of Pennsylvania have developed a gene therapy that successfully treats a form of macular degeneration in a canine model.
An interdisciplinary team of researchers from the University of Vienna (Institute of Inorganic Chemistry) and the Medical University of Vienna (Institute for Cancer Research) has successfully developed a new strategy for reducing the often serious side effects of an important class of modern anticancer drugs (tyrosine kinase inhibitors).
An enzyme that appears to play a role in controlling the brain's response to nicotine and alcohol in mice might be a promising target for a drug that simultaneously would treat nicotine addiction and alcohol abuse in people, according to a study by researchers at the Ernest Gallo Clinic and Research Center, affiliated with the University of California, San Francisco.
Pathologists at The University of Texas Health Science Center at Houston have developed a chemically modified protein that may help people with a hard-to-treat form of a genetic bleeding disorder known as Hemophilia A. The discovery and the results of pre-clinical tests appear in the May 2 issue of the Journal of Biological Chemistry.
› Verified 4 days ago
| NPI Number | 1861409849 |
| Organization Name | WALGREEN CO |
| Doing Business As | WALGREENS #03147 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 918 Riverview Dr, Kalamazoo, MI 49048 |
| Phone Number | 269-382-5445 |
News Archive
Researchers from the University of Pennsylvania have developed a gene therapy that successfully treats a form of macular degeneration in a canine model.
An interdisciplinary team of researchers from the University of Vienna (Institute of Inorganic Chemistry) and the Medical University of Vienna (Institute for Cancer Research) has successfully developed a new strategy for reducing the often serious side effects of an important class of modern anticancer drugs (tyrosine kinase inhibitors).
An enzyme that appears to play a role in controlling the brain's response to nicotine and alcohol in mice might be a promising target for a drug that simultaneously would treat nicotine addiction and alcohol abuse in people, according to a study by researchers at the Ernest Gallo Clinic and Research Center, affiliated with the University of California, San Francisco.
Pathologists at The University of Texas Health Science Center at Houston have developed a chemically modified protein that may help people with a hard-to-treat form of a genetic bleeding disorder known as Hemophilia A. The discovery and the results of pre-clinical tests appear in the May 2 issue of the Journal of Biological Chemistry.
› Verified 4 days ago
News Archive
Researchers from the University of Pennsylvania have developed a gene therapy that successfully treats a form of macular degeneration in a canine model.
An interdisciplinary team of researchers from the University of Vienna (Institute of Inorganic Chemistry) and the Medical University of Vienna (Institute for Cancer Research) has successfully developed a new strategy for reducing the often serious side effects of an important class of modern anticancer drugs (tyrosine kinase inhibitors).
An enzyme that appears to play a role in controlling the brain's response to nicotine and alcohol in mice might be a promising target for a drug that simultaneously would treat nicotine addiction and alcohol abuse in people, according to a study by researchers at the Ernest Gallo Clinic and Research Center, affiliated with the University of California, San Francisco.
Pathologists at The University of Texas Health Science Center at Houston have developed a chemically modified protein that may help people with a hard-to-treat form of a genetic bleeding disorder known as Hemophilia A. The discovery and the results of pre-clinical tests appear in the May 2 issue of the Journal of Biological Chemistry.
› Verified 4 days ago
Carelinc Medical Equipment & Supply Type: DME Supplier - Oxygen Equipment & Supplies Location: 5125 Portage Rd, Kalamazoo, Michigan 49002 Phone: (269) 273-5500 | |
Cvs Pharmacy #16332 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5350 W Main St, Kalamazoo, Michigan 49009 Phone: (269) 349-6290 | |
Cvs Pharmacy #10548 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2600 W Michigan Ave, Kalamazoo, Michigan 49006 Phone: (269) 343-4232 | |
Lincare Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2600 Millcork St, Kalamazoo, Michigan 49001 Phone: (269) 964-0030 | |
Rite Aid Pharmacy #01478 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1032 E Cork St, Kalamazoo, Michigan 49001 Phone: (269) 344-0131 |